Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > EDTXF Volume=0

<< Previous

Bullboard Posts

Next >>

Post by Domino55on Apr 29, 2021 3:50pm

195 Views

Post# 33095286

EDTXF Volume=0

Are there other micro caps with late stage P3 confirmatory trials and multiple FDA approvals that register zero share volume on a daily basis?

are there other micro caps anywhere with late stage P3 confirmatory trials and multiple FDA approvals?

OHHHH the burden and the baggage of Program B.

<< Previous

Bullboard Posts

Next >>

B2Gold stock buckles under news of labour strike in Mali